NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Exemestane|DRUG: Letrozole|DRUG: Anastrozole|DRUG: Leuprolide Acetate|DRUG: Pertuzumab|DRUG: Trastuzumab
Sponsor: Midwestern Regional Medical Center